[1] Perrone A, Giovino A, Benny J, et al. Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects [J]. Oxid Med Cell Longev,2020,2020:3818196. [2] Katz J, Caudle RM, Bhattacharyya I, et al. Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine [J]. J Periodontol,2005,76(7):1171-1174. [3] Lee KJ, Yoo JW, Kim YK, et al. Advanced glycation end products promote triple negative breast cancer cells via ERK and NF-kappaB pathway [J]. Biochem Biophys Res Commun,2018,495(3):2195-2201. [4] Qin Q, Niu J, Wang Z, et al. Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway [J]. Cardiovasc Diabetol,2013,12:37. [5] Qi W, Yang X, Ye N, et al. TLR4 gene in the regulation of periodontitis and its molecular mechanism [J]. Exp Ther Med,2019,18(3):1961-1966. [6] Korneev KV, Atretkhany KN, Drutskaya MS, et al. TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis [J]. Cytokine,2017,89:127-135. [7] Takeda K, Akira S. TLR signaling pathways [J]. Semin Immunol,2004,16(1):3-9. [8] Gurav A, Jadhav V. Periodontitis and risk of diabetes mellitus [J]. J Diabetes,2011,3(1):21-28. [9] Ren L, Fu Y, Deng Y, et al. Advanced glycation end products inhibit the expression of collagens type I and III by human gingival fibroblasts [J]. J Periodontol,2009,80(7):1166-1173. [10] Choi AJ, Ryter SW. Inflammasomes: molecular regulation and implications for metabolic and cognitive diseases [J]. Mol Cells,2014,37(6):441-448. [11] Zhang Z, Liu Q, Liu M, et al. Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II [J]. J Neuroinflammation,2018,15(1):27. [12] Zhu YJ, Wang C, Song G, et al. Toll-like receptor-2 and -4 are associated with hyperlipidemia [J]. Mol Med Rep,2015,12(6):8241-8246. [13] Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes [J]. Cell,2014,157(5):1013-1022. [14] Chen X, Gao Q, Zhou L, et al. MiR-146a alleviates inflammation of acute gouty arthritis rats through TLR4/MyD88 signal transduction pathway [J]. Eur Rev Med Pharmacol Sci,2019,23(21):9230-9237. [15] Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases [J]. Blood,2011,117(14):3720-3732. [16] Netea MG, Simon A, van de Veerdonk F, et al. IL-1beta processing in host defense: beyond the inflammasomes [J]. PLoS Pathog,2010,6(2):e1000661. [17] Barbara JA, Van ostade X, Lopez A. Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective [J]. Immunol Cell Biol,1996,74(5):434-443. [18] Ahmad R, Shihab PK, Thomas R, et al. Increased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesity [J]. Diabetol Metab Syndr,2015,7:71. |